Status:
COMPLETED
The Effect of the Alga Dunaliella Bardawil as a Source of 9-cis Retinoic Acid on Lipid Profile in Fibrate Treated Patients.
Lead Sponsor:
Sheba Medical Center
Conditions:
Low HDL Cholesterol
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
The effect of fibrates on high density lipoprotein (HDL)-cholesterol levels is suggested to be mediated by its binding to peroxisome proliferator-activated receptor-g (PPARg). Upon ligand binding, PPA...
Eligibility Criteria
Inclusion
- age 18-70 years
- Fibrate treatment (for at least 6 weeks)
- HDL-Cholesterol lower than 40mg/dl.
- Triglyceride over 150mg/dl.
Exclusion
- High CPK.
- Elevated liver functions.
- Active CHD.
- Smokers.
- Diabetes patients treated with Insulin or Avandia. HbA1C great than 8.5.
Key Trial Info
Start Date :
May 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2006
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00156169
Start Date
May 1 2001
End Date
December 1 2006
Last Update
August 12 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.